REGENERON PHARMACEUTICALS earnings per share and revenue

RGO earnings per share for the last quarter are 8.62 CHF whereas the estimation was 9.18 CHF which accounts for -6.11% surprise. Företagets omsättning för samma period uppgår till 2.84 B CHF trots den uppskattade siffran 2.91 B CHF. Estimated earnings per share for the next quarter are 9.63 CHF, and revenue is expected to reach 3.06 B CHF. Also watch annual changes over time to get a bigger picture of RGO earnings per share and revenue dynamics.